Andreas Ole Halvorsen Zentalis Pharmaceuticals, Inc

As of December 3, 2020


Andreas Ole Halvorsen Net Worth

  • Net worth is estimated to be at least $25.28B
  • Owns at least 3,943,284 units of Zentalis Pharmaceuticals, Inc stock
  • Sold an estimated value of $25.25M in the last 9 months at Zentalis Pharmaceuticals, Inc

Andreas Ole Halvorsen Trading

  • Largest purchase of shares was 725,000 units , worth over $13.05M on April 8, 2020
  • Largest sale of shares was 500,000 units , worth over $25.25M on December 3, 2020
  • In total has made about 2 transactions over 9 months
  • Usually trades in December and April, with the busiest year in 2020

VIKING GLOBAL INVESTORS LP, Viking Global Opportunities Illiquid Investments SubMaster LP, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities GP LLC, ANDREAS OLE HALVORSEN, David Ott, Sharon Rose Shabet

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Andreas Ole Halvorsen Mailing Address

  • Mailing address is C/o Viking Global Investors Lp 280 Park Ave 35th New York NY 10017 NY

Zentalis Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Anthony Sun, M.D. 2020 $561,232 - $8,100,645 $5,986,469 $287,375 $108,678 $15,044,399
Anthony Sun, M.D. 2019 $455,091 - - $918,000 $204,971 - $1,577,882
Kevin Bunker, Ph.D. 2020 $428,771 - $2,580,864 $2,993,235 $179,550 $91,174 $6,273,594
Kevin Bunker, Ph.D. 2019 $360,024 - - $275,400 $144,010 - $779,434
Alexis M. Pinto 2020 $136,923 - - $6,234,468 $152,000 $10,511 $6,533,902
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1725160/000172516021000099/proxystatement-2021.htm

Zentalis Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 10,000 units sold on October 4, 2021 by Cam Gallagher worth over $661.49K
  • In the last year, insiders at Zentalis Pharmaceuticals, Inc sold an estimated value of $75.41M and bought an estimated value of $14M
  • The most active traders are Kevin D Bunker, Chief Operating Officer,  Cam Gallagher, Director,  and Anthony ySun, President & CEO
  • Insider trading is most common in April, with the busiest year in 2021

Zentalis Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1